Panther Fusion Aptima SARS-CoV-2 Assay

Award Notice Posted

Solicitation number
W81K0420P0012
Agency
Awarded
to Gen-Probe Incorporated
Set-aside
No set-aside

Opportunity facts

Contract number
W81K0420P0012 Federal contract award
Place of performance
Gunpowder MD 21010 USA

Notice details come from SAM.gov. Updated .

About this opportunity

The U.S. Army Medical Command published an Award Notice for a sole source contract awarded to Gen-Probe Incorporated for $2,674,320. The firm fixed price contract is to provide 2674320 Panther Fusion SARS-CoV-2 assays, including 250 assay kits, 84 controls, and 840 solid cap supplies, to the Army Public Health Center for use on the Hologic Panther System. The assays allow for detection of SARS-CoV-2 from patient specimens and are needed to support expanded coronavirus testing for the Army in response to the COVID-19 pandemic.

Notice text

The APHC is acquiring Panther Fusion SARSCoV-2 assays (250-SARS-CoV-2 Assay Kit, 84–Aptima Controls, 840-Solid Cap SLT) for
use on the Hologic Panther System. The Panther Fusion SARS-CoV-2 is a qualitative test for the detection of nucleic acid from SARS CoV-2 isolated and purified from NP and OP swab specimens obtained from individuals who meet COVID-19 clinical and/or epidemiological criteria. The Panther Fusion System is an integrated nucleic acid testing system that fully automates all steps necessary to perform various Panther Fusion assays from sample processing through amplification, detection, and data reduction.

Awarded contract W81K0420P0012 to GEN-PROBE INCORPORATED for 2674320.00 on 2020-09-11.

Files

File Type Posted
JA COVID-19 SARS-CoV-2 GenProbe _approved.pdf PDF

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors